mobile header
Dr Sureshkumar A.C

Dr Sureshkumar A.C american Oncology Hospitals

Dr Sureshkumar A.C

Consultant – Nuclear Medicine

Book an Appointment
Share Profile share

Dr. Sureshkumar A.C is one of the best Nuclear Medicine Consultant in Coimbatore, with extensive expertise in advanced molecular imaging and radionuclide therapies.

With over a decade of clinical experience, he has reported 25,000+ PET-CT scans and performed 10,000+ nuclear medicine procedures, demonstrating strong proficiency in both diagnostic and therapeutic nuclear medicine.

He holds prestigious qualifications, including DRM from Tata Memorial Hospital, DNB in Nuclear Medicine, and is a Fellow of the European Board of Nuclear Medicine (FEBNM). He has also completed a Master’s in Oncologic Imaging from the University of Pisa, Italy, and is a certified Radiation Safety Officer.

His areas of specialization include PET-CT imaging, theranostics, and targeted radionuclide therapies, such as Lutetium-177 therapy and radioiodine treatment. His expertise further extends to nuclear oncology, nuclear cardiology, and advanced procedures like transarterial radioembolization (TARE) for liver tumors.

Dr. Sureshkumar has played a pivotal role in establishing and leading nuclear medicine departments, contributing to infrastructure planning, protocol development, and quality assurance.

He collaborates closely with oncology teams to deliver precise, personalized, and outcome-driven care, ensuring optimal clinical outcomes for patients.

  • MBBS, K.A.P.V. Govt Medical College (Dr. M.G.R Medical University), Tamil Nadu - 2005
  • Diploma in Radiation Medicine (DRM), Radiation Medicine Centre, Tata Memorial Hospital Annexe, Mumbai, Maharashtra - 2010
  • Fellow of European Board of Nuclear Medicine (FEBNM), European Board of Nuclear Medicine - 2012
  • DNB, Nuclear Medicine, Apollo Hospitals, Chennai, Tamil Nadu - 2014
  • Master in Oncological Imaging, University of Pisa, Italy - 2023
  • Junior Consultant, Dr. Kamakshi Memorial Hospitals, Chennai, Tamil Nadu - June 2010 - March 2012
  • Senior Resident and Registrar, Apollo Hospitals, Chennai, Tamil Nadu - March 2012 - May 2015
  • Consultant and Department In Charge, Amala Institute of Medical Sciences, Amala Nagar, Thrissur, Kerala - May 2015 - March 2018
  • Senior Consultant, American Oncology Institute at Royalcare Super Specialty Hospital, Coimbatore, Tamil Nadu - April 2018 - December 2019
  • Registrar, Ministry of Health, Kuwait - Jan 2020 - Apr 2020
  • PET-CT & Hybrid Molecular Imaging
  • Theranostics & Targeted Radionuclide Therapy
  • Oncologic Nuclear Medicine Imaging & Treatment Response Assessment
  • Nuclear Cardiology & Nuclear Urology
  • Pre-therapy Planning, Dosimetry & Radiation Safety
  • Single centre experience of radioiodine therapy in the management of Thyrotoxicosis: Retrospective analysis of 14 years. Sureshkumar Chandran, Shelley Simon, Indirani Elangovan, Department of Nuclear Medicine, Apollo Main Hospitals, Chennai, Tamil Nadu, India. Journal of International Medical Sciences Academy, April - June 2015, Vol. 28, No. 2.
  • Diagnostic importance of contrast enhanced 18F-fluorodeoxyglucose positron emission computed tomography in patients with tumor induced osteomalacia: Our experience. Avani S. Jain, Simon Shelley, Indirani Muthukrishnan, Shilpa Kalal, Jaykanth Amalachandran, Sureshkumar Chandran. Department of Nuclear Medicine and PET-CT, Apollo Hospitals, Chennai, Tamil Nadu, India. Indian Journal of Nuclear Medicine 2016;31:14-9.

Presentations

  • “Comparison of fixed low dose versus high dose radioactive iodine (RAI) for the treatment of hyperthyroidism: Retrospective multifactorial analysis impacting the outcome of therapy”, European Congress, Milan, Italy, 2012.
  • “Diagnostic gain of SPECT-CT in skeletal scintigraphy in oncologic and non-oncologic applications”, European Congress, Milan, Italy, 2012.
  • “Various Rh TSH protocols in differentiated thyroid cancer management”, CME organised by Thyrogen, Chennai, 2014.
  • “PET/MR in gynecological malignancies”, Gynaecological Imaging and Interventions CME organised by GLAIRE, Global Hospitals, Chennai, 2015.
  • “Efficacy of 18F-FDG PET-CT in the detection of recurrent gynaecological malignancies”, IPET 2015, Vienna, October 2015.
TNMC: 79004